药品行业关乎民生,推动其品牌化良性经营,使之在市场大潮中发展壮大并达到有效传播,是广告业界和同行义不容辞的责任。工欲善其事,必先利其器。长期以来,中国药业品牌化的经营匮乏,广告难做,相关法规政策的桎梏等一系列问题,从某种意义上讲,是由其本身混乱的竞争环境和非法生产直接引起的。因为一部分药品企业的虚假举措和不负责任的行为,连带或直接导致多数广告公司蒙受不白之冤,药品失信于市场,让医药广告背上了虚假的阴影,药业品牌从立意到传播,充满困难。广告,药品管理双项法规的制定,有效遏止了中国医药在发展进程中的畸形态势,药品广告审查力度和标准的不断增强完善,不是给广告,药品产业的磨合发展增加了阻力,而是促进了协作,使两者在市场营销、资源等诸方面达到和谐共享,从而激活其潜在优势,可以更务实、更有效地将广告传播,药业品牌化生产真正推到一种齐头并进、共谋发 The pharmaceutical industry is about people’s livelihood, promoting its brand management and making it grow and expand in the tide of the market and achieve effective communication. It is the bounden duty of the advertising industry and its peers. Workers want good things, must first sharpen. For a long time, China’s pharmaceutical brand management lack of advertising is difficult to do, the relevant laws and regulations and a series of problems, in a sense, is confused by its own confusion and illegal production directly caused. Because some of the false actions of pharmaceutical companies and irresponsible behavior, together or directly lead to most advertising companies suffered unjust injustice, drug dishonesty in the market, so that pharmaceutical advertising back a false shadow, the pharmaceutical brand from conception to dissemination, Full of difficulties. The formulation of the double regulations on advertising and drug administration effectively stopped the abnormal situation in the development of Chinese medicine. The review and standardization of drug advertisements continued to improve and improve instead of adding resistance to the running-in of the advertising and pharmaceutical industries, So that the two can be harmoniously shared in various fields such as marketing and resources so as to activate their potential advantages and to push the communication and brand production of medicine to a more pragmatic and effective push to go hand in hand